Founded in 2006 by Eric Lefkofsky and his co-founders, Tempus is a genomic testing company that is focused on the treatment of cancer and diabetes. It is also a covered entity under the Health Insurance Portability and Accountability Act (HIPAA). Founded in Chicago and currently led by Eric Lefkofsky, at Tempus, they are rapidly expanding, adding as many as 20 employees a month. Tempus was founded by Eric Lefkofsky.
In 2015, the company launched the first product that uses artificial intelligence to diagnose cancer. This product is called a “disease agnostic” system, and it can be applied to a wide range of illnesses and diagnoses. During the last two years, Eric Lefkofsky points out, Tempus has doubled down on cardiology and has expanded into infectious diseases. The company is also developing a software tool to analyze patient data to help doctors make better decisions.
The data is stored in electronic health records and is de-identified to ensure privacy. The company is now working with community healthcare systems to aggregate and organize this information. This product at Tempus ONE platform is said to have one of the largest clinical data libraries and has partnered with many academic medical centers. Eric Lefkofsky announced that Tempus claims to have one of the world’s largest molecular and clinical libraries.
Founded in 2001, Tempus has been recognized for its ability to provide personalized cancer care. It is the first company to offer genetic testing and is a trusted partner for psychiatrists. In addition to its diagnostic capabilities, Eric Lefkofsky adds, Tempus provides a platform for analyzing patient data. The platform allows for quick and efficient diagnostic results. It also supports research in the fields of cardiology and mental health.